
Cooper Companies (COO) Stock Forecast & Price Target
Cooper Companies (COO) Analyst Ratings
Bulls say
Cooper Companies is positioned favorably because its two-engine model in CooperVision and CooperSurgical supports mid-single-digit organic revenue growth, with management also guiding to stronger myopia management contribution and continued gains in specialty lenses and fertility. The company has repeatedly shown operating leverage, with gross margin at 66.7% and operating margin at 26.3% in one period, while EPS benefited from lower SG&A and R&D as well as rising free cash flow guidance to $650M. Shareholder returns are also compelling, as the strategic review led to a larger $3B buyback authorization and could unlock additional value if CSI is monetized and redeployed into repurchases.
Bears say
Cooper Companies is facing a weaker fundamental setup as F3Q26 revenue missed consensus at $1.066B and management cut FY26 revenue guidance to $4.229B-$4.252B and EPS guidance to $4.51-$4.55, reflecting softer demand rather than a one-off issue. CooperVision, the larger growth engine, was flat organically at $717M as US channel inventory de-stocking and share loss pressured the franchise, with CVI guidance reduced to 1%-2% organic growth and further softness expected into F4Q26. CooperSurgical also slowed, with sales up only 3% organically to $349M, while a higher FY27 tax rate of 17.5% and slower EPS growth limit earnings leverage and reinforce the negative outlook.
This aggregate rating is based on analysts' research of Cooper Companies and is not a guaranteed prediction by Public.com or investment advice.
Cooper Companies (COO) Analyst Forecast & Price Prediction
Start investing in Cooper Companies (COO)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Cooper Companies (COO) Forecast
Cooper Companies (COO) Analyst Forecast & Price Prediction
Start investing in Cooper Companies (COO)
Order type
Buy in
Order amount
Est. shares
0 shares